Pharma Veterans

The Greed in Healthcare System – Asrar Qureshi’s Blog Post 1048 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1048 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Anna Shvets Credit: Andrea Piacquadio This post is inspired by an article by Donald M. Berwick, published in JAMA – Journal of American Medical Association. Link at the end. Preamble The healthcare in most countries has become a huge profit-making industry. Hospitals, physicians, pharmacies, drug suppliers are all part of the profiteering. The healthcare institutions advertise that ‘they keep the patient in the center’; this appears true. They do keep the patients in the center to slaughter them financially, mercilessly.  I am borrowing from the JAMA® article mentioned above, which is titled ‘Salve Lucrum: The Existential Threat of Greed in US Health C...

New Drug Modalities – Asrar Qureshi’s Blog Post 1047 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1047 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Edward Jenner Credit: Ivan Samkov Credit: Jonathan Borba This post is based on Boston Consulting Group article authored by Lu Chen, Brian Bush, Mike Brochu, and Gian King. Link at the end. Preamble The second annual report from BCG reviews the growth of new drug modalities. The report tracks the progress in each of the six categories of novel modalities in terms of number of products and pipeline revenue. It will help to see which modalities are progressing more rapidly and its implication for patients and biopharma companies and investors. For us in Pakistan, most of this may sound completely foreign, but we are already using many of these products. New Modalities L...

Personality Assessment Using AI – Asrar Qureshi’s Blog Post 1046 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1046 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Andy Barbour Credit: Antoni Shkraba Credit: Eden Kefale This post is inspired on an article written by Eliot Gattegno and Nadav Klein, and published in Knowledge by INSEAD. Link at the end. Preamble This post may be considered as an extension of the previous post with particular focus on AI. One opportunity for deploying technology is to assess personality, an individual’s characteristics that remain consistent across different social situations. People with similar personalities will act similarly in important ways. This means that personality information can be used to predict likely matches and mismatches between colleagues who work together in teams, ...

OCEAN – Big Five Personality Traits – Asrar Qureshi’s Blog Post #1045 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1045 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Alireza Heidarpour Credit: Khalida11 Credit: Muhammad Shamaoon Malik Credit: murat esitabir Credit: Plus Minus Preamble Our quest for knowing ourselves is ancient though the degrees and individual interests may vary.  The Big Five Personality Traits, also known as OCEAN or CANOE are a psychological model that describes five broad dimensions of personality: Openness, Conscientiousness, Extraversion, Agreeableness, and Neuroticism. These traits are thought to be stable throughout the lifetime of an individual. In this blog post, we shall look at the model, what does it represent, how reliable it is, and how it can be put to good use. Personality D...

More Future Arenas of Competition – Asrar Qureshi’s Blog Post #1044 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1044 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Anastasia Shuraeva Credit: Craig Adderley Credit: Gustavo Fring This blogpost is based on a survey report of MGI – Mckinsey Global Institute. Owing to the enormity of subject, this is the third and the last post on the subject. Links at the end. Preamble The MGI survey identified 12 arenas from 2005 to 2020, in which certain companies grew much bigger than others. Based on this learning; they also identified 18 arenas of today which possibly would shape the global economy, generating $29 trillion to $48 trillion in revenue by 2040. More Out of 18 Future Big Arenas Electric Vehicles – EVs Electric Vehicles’ technology has been around since the inventio...

Future Big Arenas of Competition – Asrar Qureshi’s Blog Post #1043 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1043 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: cottonbro studio Credit: Kampus Production Credit: Nataliya Vaitkevich Credit: Sanket Mishra Credit: Vika Glitter This blogpost is based on a survey report of MGI – Mckinsey Global Institute. Owing to the enormity of subject, it will take more than one blog post. Link at the end. Preamble The MGI survey identified 12 arenas from 2005 to 2020, in which certain companies grew much bigger than others. Based on this learning; they also identified 18 arenas of today which possibly would shape the global economy, generating $29 trillion to $48 trillion in revenue by 2040. I presented 12 previous arenas in the last blogpost. I shall now discuss the 18 future ...

Present and Future Big Arenas of Competition – Asrar Qureshi’s Blog Post #1042 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1042 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Anna Nekrashevich Credit: Craig Adderley Credit: Nataliya Vaitkevich  This blogpost is based on a survey report of MGI – Mckinsey Global Institute. Owing to the enormity of subject, it will take more than one blog post. Link at the end. Preamble The McKinsey Global Institute was established in 1990. Its mission is to provide a fact base to support decision making on the economic and business issues most critical to the companies around the world and policy leaders. MGI works independently and none of its work is commissioned or funded by any business, government, or any other institution. Chris Bradley, Michael Chui, Kevin Russel, Kweil...

Artificial General Intelligence (AGI) – Asrar Qureshi’s Blog Post #1041 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1041 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Bianca Salgado Credit: Mikael Blomkvist Credit: Pavel Danilyuk This blogpost also partakes information from a McKinsey article. Link at the end. Preamble Artificial General Intelligence – AGI – is a theoretical AI system with capabilities that are as good as humans.  AGI refers to an advanced form of artificial intelligence that can perform any intellectual task a human can do, with comparable levels of understanding, reasoning, and adaptability. Unlike current AI systems, which are domain-specific and limited to predefined tasks (narrow AI), AGI would possess general reasoning abilities and the capacity to learn and apply knowledge across a w...